Share ownership 3SBio Inc.

1530

KYG8875G1029

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 08:08:04 06/02/2026 GMT			5-day change	1st Jan Change
22.94 ^HKD	-0.78%		-1.55%	-5.13%

12-02	3SBio Seeks HK$3.12 Billion via Share Sale	MT
12-02	3SBio to place 105.2 million shares	RE

Share class: 3SBio Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,416,800,912	1,743,695,812 ( 72.15 %)	21,227,000 ( 0.8783 %)	72.15 %

Major shareholders: 3SBio Inc.

Name	Equities	%	Valuation
Jing Lou 21.84 %	554,183,428	21.84 %	1 722 M $
China Universal Asset Management Co., Ltd. 5.931 %	150,516,500	5.931 %	468 M $
Fullgoal Fund Management Co., Ltd. 2.934 %	74,462,997	2.934 %	231 M $
BlackRock Fund Advisors 2.531 %	64,249,500	2.531 %	200 M $
HuaAn Fund Management Co., Ltd. 1.414 %	35,898,000	1.414 %	112 M $
Zhong Ou Asset Management Co., Ltd 1.412 %	35,834,500	1.412 %	111 M $
ICBC UBS Asset Management Co. Ltd. 1.305 %	33,133,000	1.305 %	103 M $
Dong Mei Su 0.9608 %	24,384,630	0.9608 %	76 M $
Bosera Asset Management Co., Ltd. 0.6943 %	17,621,500	0.6943 %	55 M $
BlackRock Advisors (UK) Ltd. 0.6843 %	17,368,500	0.6843 %	54 M $
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	27.61%
Individuals	23.28%
Unknown	49.11%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	23.28%
China	21.99%
United States	2.58%
United Kingdom	1.23%
Hong Kong	0.92%
Netherlands	0.48%
Japan	0.08%
Singapore	0.07%
Switzerland	0.07%
Canada	0.06%
Australia	0.03%
Norway	0.03%
Germany	0.02%
Ireland	0.02%
Luxembourg	0.01%
France	0.01%

Based on 1000 largest holdings

3SBio Inc is an investment holding company mainly engaged in the development, production, marketing and sale of pharmaceutical products. The Companyâ€™s core products include several biopharmaceutical drugs, TPIAO, recombinant human erythropoietin(rhEPO) products, with brand of EPIAO and SEPO, Yisaipu, Cipterbin and a small molecule drug, Mandi and tumor necrosis factor (TNF). Through its subsidiaries, the Company is engaged in project management and consultation. The Company still engages in developing innovative biological products, including mAbs, bi-specific antibodies and fusion proteins, and a number of small molecule drugs, both innovative and generic, in the areas of nephrology, oncology, auto-immune and inflammatory diseases, ophthalmology and dermatological diseases. The Company distributes its products within the domestic market and to overseas markets.

Employees

6,268

Sector

Pharmaceuticals

Calendar

03-30 - Q4 2025 Earnings Release (Projected)

More about the company